Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lung

被引：13
|
作者：
Ma, Ada T. W. [1 ]
Chan, Wai Kong [2 ]
Ma, Edmond S. K. [2 ]
Cheng, Thomas [3 ]
Cheng, Paul N. M. [1 ]
机构：
[1] 813 Med Ctr, Div Med Oncol, Hong Kong, Hong Kong, Peoples R China
[2] Hong Kong Sanat & Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[3] Hong Kong Sanat & Hosp, Dept Nucl Med, Hong Kong, Hong Kong, Peoples R China
来源：
ACTA ONCOLOGICA | 2012年 / 51卷 / 04期
关键词：
EGFR MUTATION; CARCINOMA;
D O I：
10.3109/0284186X.2011.636757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：557 / U169
页数：3
相关论文
共 50 条
  • [1] Imatinib treatment for gefitinib-resistant lung cancer harboring epidermal growth factor receptor mutation
    Fukuhara, Tatsuro
    Treda, Cezary Jan
    Sakakibara, Tomohiro
    Inoue, Akira
    Ebina, Masahito
    Nukiwa, Toshihiro
    [J]. CANCER RESEARCH, 2012, 72
  • [2] Autophagic degradation of epidermal growth factor receptor in gefitinib-resistant lung cancer by celastrol
    Xu, Su-Wei
    Law, Betty Yuen Kwan
    Mok, Simon Wing Fai
    Leung, Elaine Lai Han
    Fan, Xing Xing
    Coghi, Paolo Saul
    Zeng, Wu
    Leung, Chung-Hang
    Ma, Dik-Lung
    Liu, Liang
    Wong, Vincent Kam Wai
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) : 1576 - 1588
  • [3] The Role of Histone Deacetylase in the Maintenance of Gefitinib-Resistant Lung Cancer Stem Cells with Epidermal Growth Factor Receptor Mutation
    Nurwidya, F.
    Takahashi, F.
    Hidayat, M.
    Wirawan, A.
    Baskoro, H.
    Kato, M.
    Tajima, K.
    Shimada, N.
    Andarini, S. L.
    Yunus, F.
    Takahashi, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Formation of Gefitinib-Resistant Lung Cancer Cell Lines and their Changes in Epidermal Growth Factor Receptor Signaling Pathway
    Song, Yunxi
    Ma, Jianxin
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 (05) : 1269 - 1278
  • [5] Tuberculosis in epidermal growth factor receptor mutation in lung adenocarcinoma on treatment with gefitinib/erlotinib
    Gothi, D.
    Spalgais, S.
    [J]. INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 1 - 1
  • [6] Clinical usefulness of gefitinib for non-small-cell lung cancer with a double epidermal growth factor receptor mutation
    Oikawa, Takefumi
    Ohira, Tatsuo
    Otani, Keishi
    Hagiwara, Masaru
    Konaka, Chimori
    Ikeda, Norihiko
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 329 - 333
  • [7] Spontaneous regression in a primary adenocarcinoma of lung with epidermal growth factor receptor mutation
    Ahmad, Farhan
    Singh, Shalini
    Kumari, Niraj
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1817 - 1819
  • [8] Effect of opioid receptor agonists in gefitinib-resistant non-small cell lung cancer
    Suzuki, Atsuo
    Kuzumaki, Naoko
    Hosoya, Takahiro
    Narita, Michiko
    Tsukiji, Kozue
    Suzuki, Masami
    Uezono, Yasuhito
    Morita, Hiroshi
    Suzuki, Tsutomu
    Narita, Minoru
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 105P - 105P
  • [9] Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification
    Yoshida, Takeshi
    Okamoto, Isamu
    Okamoto, Wataru
    Hatashita, Erina
    Yamada, Yuki
    Kuwata, Kiyoko
    Nishio, Kazuto
    Fukuoka, Masahiro
    Janne, Pasi A.
    Nakagawa, Kazuhiko
    [J]. CANCER SCIENCE, 2010, 101 (01): : 167 - 172
  • [10] Small-Cell Carcinoma With an Epidermal Growth Factor Receptor Mutation in a Never-Smoker With Gefitinib-Responsive Adenocarcinoma of the Lung
    Alam, Naheed
    Gustafson, Karen S.
    Ladanyi, Marc
    Zakowski, Maureen F.
    Kapoor, Atul
    Truskinovsky, Alexander M.
    Dudek, Arkadiusz Z.
    [J]. CLINICAL LUNG CANCER, 2010, 11 (05) : E1 - E4
12345